<--- Back to Details
First PageDocument Content
Acquired hemolytic anemia / Coagulation system / Hematopathology / Nephrology / Syndromes / Thrombotic thrombocytopenic purpura / Thrombocytopenia / Hemolytic-uremic syndrome / Von Willebrand factor / Medicine / Health / Anatomy
Date: 2007-02-13 16:36:50
Acquired hemolytic anemia
Coagulation system
Hematopathology
Nephrology
Syndromes
Thrombotic thrombocytopenic purpura
Thrombocytopenia
Hemolytic-uremic syndrome
Von Willebrand factor
Medicine
Health
Anatomy

Disseminated Malignancy Misdiagnosed as Thrombotic Thrombocytopenic Purpura: A Report of 10 Patients and a Systematic Review of Published Cases Kristin K. Francis, Nalini Kalyanam, Deirdra R. Terrell, Sara K. Vesely and

Add to Reading List

Source URL: www.ouhsc.edu

Download Document from Source Website

File Size: 600,95 KB

Share Document on Facebook

Similar Documents

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

DocID: 1vj68 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uEgV - View Document

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics  September 29-30, 2016 Orlando, USA

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics September 29-30, 2016 Orlando, USA

DocID: 1uvE8 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uvxq - View Document

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

DocID: 1tmLJ - View Document